ENTITY
Intron Biotechnology

Intron Biotechnology (048530 KS)

10
Analysis
Health CareSouth Korea
iNtRON Biotechnology, Inc. is a bio-venture developing bio-active agents targeting infectious organisms and driving its commercial use.
more
bearishDevsisters
17 Nov 2022 04:55

KOSDAQ150 Index Rebalance: 11 Changes with a Couple of Surprises

There are 11 changes at the Dec rebal: mostly in line with forecasts. SillaJen is a surprise add; Devsisters is a surprise delete. Short interest...

Logo
469 Views
Share
bullishWCP
16 Nov 2022 22:04

KOSPI 200 & KOSDAQ 150 Constituent Changes: Several Surprises

This post details the constituent changes of the KOSPI 200 and KOSDAQ 150 and highlights several surprises along with the passive flow estimations.

Logo
460 Views
Share
bullishHPSP
01 Nov 2022 04:40

KOSDAQ150 Index Rebalance Preview: Big Churn in IT, Healthcare Stocks

There could be 11 changes at the Dec rebalance. Most changes are high probability and will result in a big churn in the IT & Healthcare sectors....

Logo
383 Views
Share
bullishISC Co Ltd
12 Jul 2022 07:00

KOSDAQ150 Index Rebalance Preview (Dec 2022): Changes Galore Early in the Review Period

One third of the way through the review period, we see 11 potential changes. The potential adds have outperformed the potential deletes and there...

Logo
431 Views
Share
11 Mar 2020 00:58

Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea

It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...

Logo
351 Views
Share
x